OSE Immunotherapeutics SA (DE:6OP)
FRANKFURT:6OP
OSE Immunotherapeutics SA (6OP) Ownership Overview
0.03%
Mutual Funds
0.06% ETFs
99.91% Public Companies and
Individual Investors
The ownership structure of OSE Immunotherapeutics SA (DE:6OP) stock is a mix of institutional, retail, and individual investors. , and 99.91% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,130 | Institution | 0.06% | 44,550 | |
| 6,923 | Institution | 0.03% | 23,490 | |
| 1 | Institution | <0.01% | 3 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,923 | Institution | 0.03% | 23,490 | |
| 1 | Institution | <0.01% | 3 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns OSE Immunotherapeutics SA (DE:6OP)?
Currently, no data Available
What percentage of OSE Immunotherapeutics SA (DE:6OP) stock is held by institutional investors?
Currently, no data Available
What percentage of OSE Immunotherapeutics SA (DE:6OP) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.91% of OSE Immunotherapeutics SA (DE:6OP) stock is held by retail investors.
Who owns the most shares of OSE Immunotherapeutics SA (DE:6OP)?
Dimensional owns the most shares of OSE Immunotherapeutics SA (DE:6OP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.